Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of salpingostomy, laparotomy, and methotrexate on hysterosalpingography after ectopic pregnancy
IRCT20201111049352N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Apr 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of methotrexate in Ectopic pregnancy (EP) (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Hysterosalpingography findings. Started Apr 2019; status: completed.
02
Drugs
methotrexate
03
Conditions
Ectopic pregnancy (EP)
Beyond the preview
Go deeper on IRCT20201111049352N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201111049352N1.